Why Millions Survive Cancer (Record no. 295520)

MARC details
000 -LEADER
fixed length control field 02506nam a2200157Ia 4500
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780199658756
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99406 PEC-W
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Lauren Pecorino
245 ## - TITLE STATEMENT
Title Why Millions Survive Cancer
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Oxford ; New York
Name of publisher, distributor, etc. Oxford University Press
Date of publication, distribution, etc. 2011
300 ## - PHYSICAL DESCRIPTION
Extent xviii, 223 pages, [4] pages of plates : illustrations (some color) ; 23 cm
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Introduction to the good news -- What is cancer? -- Carcinogens: how they work and our defense against them -- All we had to do was quit -- Too much of a good thing -- The great escape -- You are what you eat (and do) -- A fairy tale: finding the cure to leukemia -- Cancer screening works! -- Let's talk about it -- How to starve a tumor -- A vaccine against cervical cancer -- A fit like a glove -- Where do we go from here?
520 ## - SUMMARY, ETC.
Summary, etc. More than 12 million cancer survivors just in the United States alone are alive today as a result of the extraordinary advances in science and medicine. In Why Millions Survive Cancer, Lauren Pecorino illuminates the enormous recent progress in fighting cancer, painting an intriguing portrait of scientific breakthroughs, the leading scientists behind these key discoveries, and the steps that we can all take to reduce our exposure to cancer.The struggle against cancer has been long and difficult, but as Pecorino shows, the tide is changing, and changing rapidly. Treatments are becoming gentler and more effective. Many newly developed drugs have fewer side effects and can be administered as a pill rather than intravenously, giving patients a better quality of life. Better response rates are occurring for treatments that are targeted against the genetic characteristics of a tumor. Advances in instrumentation, robotics and imaging have led to more precise and less invasive surgical procedures. And public awareness about carcinogens is spreading and, increasingly, people are avoiding cigarettes, alcohol, and excessive exposure to the sun. As Pecorino discusses these exciting new developments, she provides readers with fascinating accounts of medical research and the discoveries we have made about the nature of cancer and the ways we can defeat it. For instance, we learn the stories behind such important new drugs as Avastin, Gardasil (the world\\\'s first cervical cancer vaccine), Herceptin, and Gleevec, the development of which unfolded \\\like a fairy tale with a happy ending.\\\
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer --Treatment. Cancer. Cancer --Prevention.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Book
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Date last checked out Price effective from Koha item type
        Dept. of Computational Biology and Bioinformatics Dept. of Computational Biology and Bioinformatics Processing Center 01/09/2015 3 616.99406 PEC-W DCB2340 26/07/2021 07/10/2020 01/09/2015 Book